ScholarIQanswers from OpenAlex & ORCID
Earl D. Silverman
ResearcherPublications, citations & collaboration network
Earl D. Silverman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Earl D. Silverman have?
ScholarIQindexed works
Earl D. Silverman has 390 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Earl D. Silverman have?
ScholarIQcitation count
Earl D. Silverman has 23,542 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Earl D. Silverman?
ScholarIQh-index
Earl D. Silverman has an h-index of 83 in OpenAlex.
What is the i10-index of Earl D. Silverman?
ScholarIQi10-index
Earl D. Silverman has an i10-index of 246 in OpenAlex.
What is the ORCID of Earl D. Silverman?
ScholarIQorcid
The ORCID for Earl D. Silverman is on the source record.
What is the OpenAlex record for Earl D. Silverman?
ScholarIQopenalex
The OpenAlex for Earl D. Silverman is on the source record.
What are the most-cited papers on Earl D. Silverman?
ScholarIQmost cited works
Factors influencing success of clinical genome sequencing across a broad spectrum of disorders
Jenny C. Taylor, Hilary C. Martin, Stefano Lise, John Broxholme, Jean‐Baptiste Cazier, Andy Rimmer, Alexander Kanapin, Gerton Lunter, Simon Fiddy, Chris Allan, A.R. Aricescu, Moustafa Attar, Christian Babbs, Jennifer Becq, David Beeson, Celeste Bento, P Bignell, Edward Blair, Veronica J. Buckle, Katherine R. Bull, Ondřej Cais, Holger Cario, Helen Chapel, Richard R. Copley, Richard J. Cornall, Jude Craft, Karin Dahan, Emma E. Davenport, Calliope A. Dendrou, Olivier Devuyst, Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty
Identification of <i>IRAK1</i> as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus
Chaim O. Jacob, Jiankun Zhu, Don Armstrong, Mei Yan, Jie Han, Xin J. Zhou, James A. Thomas, Andreas Reiff, Barry L. Myones, Joshua O. Ojwang, Kenneth M. Kaufman, Marisa Klein‐Gitelman, Deborah McCurdy, Linda Wagner‐Weiner, Earl D. Silverman, Julie T. Ziegler, Jennifer A. Kelly, Joan T. Merrill, John B. Harley, Rosalind Ramsey‐Goldman, Luis M. Vilá, Sang‐Cheol Bae, Timothy J. Vyse, Gary S. Gilkeson, Patrick M. Gaffney, Kathy L. Moser, Carl D. Langefeld, Raphael Zidovetzki, Chandra Mohan
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Nicolino Ruperto, D. Lovell, R. Cuttica, Patricia Woo, SM Meiorin, Carine Wouters, Earl D. Silverman, Zsolt J. Balogh, Michael Henrickson, Joyce Davidson, Ivan Foeldvari, Lisa F. Imundo, Gabriele Simonini, J Oppermann, Stephen Xu, Yaung‐Kaung Shen, Sudha Visvanathan, Adedigbo A. Fasanmade, Alan Mendelsohn, Alberto Martini, Edward H. Giannini